Interventional Pilot Study to Evaluate the Effect of a Resveratrol-based Nasal Spray Associated With Carboxymethylbetaglucan in Isotonic Solution in the Prevention of RTI in Children With Pre-school Wheezing

Status: Unknown
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

To determine whether or not preventive administration of resveratrol in the form of a nasal spray is effective in reducing the number of asthma exacerbations typical of preschool wheezing children who develop viral infections.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 3
Maximum Age: 6
Healthy Volunteers: t
View:

• Children diagnosed with wheezing

‣ Patients aged between 3 and 6 years (inclusive) at the time of enrollment of both genders

⁃ Signature of the informed consent

⁃ Availability of a mobile phone capable of installing VIR@PP

Locations
Other Locations
Italy
University of Campania Luigi Vanvitelli
RECRUITING
Naples
Contact Information
Primary
Michele Miraglia del Giudice, Prof
Michele.MIRAGLIADELGIUDICE@unina2.it
0815665470
Backup
Michele Miraglia del Giudice, Prof.
Michele.MIRAGLIADELGIUDICE@unina2.it
0815665470
Time Frame
Start Date: 2022-11-01
Completion Date: 2024-05-31
Participants
Target number of participants: 252
Treatments
Active_comparator: Resveratrol + CMG
Medical device: nasal spray based on resveratrol associated with carboxymethylbetaglucan in isotonic solution
Placebo_comparator: Isotonic solution
Medical Device with isotonic solution
Related Therapeutic Areas
Sponsors
Leads: Noos S.r.l.

This content was sourced from clinicaltrials.gov